β-Caryophyllene – Overview
One of the most common, most famous, most studied and potentially most beneficial of the 30,000 terpenes found in the plant world is β-Caryophyllene. One could almost call it the ‘magic’ terpene, as it has been found in various studies to be:
Anxiolytic (lowers anxiety)
Anti-cancer, enhancing apoptosis
Neuro-protective (protects against permanent neurological damage when taken after injury)
Anti-nociceptive (lowers the experience of pain)
Anti-alcoholism (lowers desire for alcohol)
Anti-smoking (lowers desire for tobacco)
Many of these studies have been done in rats and other non-human animals. However, the evidence is rather clear that Beta Caryophyllene can be extraordinarily beneficial in a number of ways.
β-Caryophyllene is a CB2 agonist, and it is likely that it is in this capacity that it provides for the large number of beneficial effects, while providing for no meaningful psychoactive effects.
β-Caryophyllene is an FDA approved food additive, and is found widely in the plant world, including black pepper, cloves, basil, lavender, cinnamon leaves, copaiba, rosemary and hops. It is used both for its flavor and its spiciness. It can be found in food including chewing gum, soaps and detergents, as well as in a variety of blends of MONQ Therapeutic Air.
The Chemistry (Okay – this part may be boring, and you can skip on if you’d like)
Isoprene, the basic building block of all terpenes, has a basic formula of C5H8 (5 carbon atoms and 8 hydrogen atoms). Sesquiterpenes, including
β-Caryophyllene, have a basic formula of C15H24, as they consist of 3 isoprene units connected together.
Beta-Caryophyllene is a bicyclic sesquiterpene, or, in English, it is a terpene with two rings, and consists of 3 connected isoprene units. Its molecular weight is 204.35. It was first synthesized in 1964.
Please note that while the above information relates specifically to studies of β-Caryophyllene, and β-Caryophyllene is found in each of the various MONQ blends, no claim is made that any of the MONQ blends actually act in any of the ways discussed in this article. MONQ has been neither evaluated nor approved of by the FDA, and no claims are made regarding the diagnosis or treatment of any medical condition, illness or disease.